Sun Pharmaceuticals Industries Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 5,214.01 | 4,580.81 | 5,758.02 |
| Operating Expense | 3,789.09 | 3,737 | 3,745.61 |
| Net Profit | 863.29 | 237.82 | 867.60 |
| Net Profit Margin | 16.56 | 5.19 | 15.07 |
| Earning Per Share | 3.60 | 1 | 3.60 |
| EBIDTA | 1,424.92 | 843.81 | 2,012.41 |
| Effective Tax Rate | 2.27 | 2.38 | 26.54 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 5214.01 |
| Operating Expense | 3789.09 |
| Net Profit | 863.29 |
| Net Profit Margin | 16.56 |
| Earning Per Share | 3.60 |
| EBIDTA | 1424.92 |
| Effective Tax Rate | 2.27 |
Invest in Sun Pharmaceuticals Industries Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 20,275.17 | 20,812.14 | 15,585.98 |
| Operating Expenses Annual | 14,775.28 | 14,389.54 | 12,917.42 |
| Operating Profit Annual | 5,834.35 | 3,814.10 | 2,044.91 |
| Interest Annual | 784.08 | 472.18 | 388.10 |
| Depreciation | 1,600.62 | 1,600.87 | 1,349.95 |
| Net Profit Annual | 2,858.18 | 1,690.72 | -99.99 |
| Tax Annual | 591.47 | 50.33 | 406.85 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 20,275.17 |
| Operating Expenses Annual | 14,775.28 |
| Operating Profit Annual | 5,834.35 |
| Interest Annual | 784.08 |
| Depreciation | 1,600.62 |
| Net Profit Annual | 2,858.18 |
| Tax Annual | 591.47 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 410.28 | 419.53 | 351.06 |
| Cash Flow from Operations | -292.42 | 507.08 | 7,636.36 |
| Cash Flow from Investing | -265.35 | -685.64 | -2,697.04 |
| Cash Flow from Financing | 473.95 | 169.31 | -4,870.85 |
| Cash Flow at the End | 326.46 | 410.28 | 419.53 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 410.28 |
| Cash Flow from Operations | -292.42 |
| Cash Flow from Investing | -265.35 |
| Cash Flow from Financing | 473.95 |
| Cash Flow at the End | 326.46 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 28.78 | 32.43 | 24.56 |
| PBIT Margin (%) | 20.88 | 24.73 | 15.90 |
| PBT Margin (%) | 20.85 | 24.68 | 15.86 |
| Net PROFIT Margin (%) | 14.10 | 8.12 | -0.64 |
| Return On Networth / Equity (%) | 12.05 | 13.89 | -5.19 |
| Return On Networth /Employed (%) | 12.22 | 16.26 | 7.47 |
| Return On Assets (%) | 8.32 | 5.36 | -0.30 |
| Total Debt / Equity (X) | 0.40 | 0.27 | 0.24 |
| Asset Turnover Ratio (%) | 0.59 | 0.66 | 0.47 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 28.78 |
| PBIT Margin (%) | 20.88 |
| PBT Margin (%) | 20.85 |
| Net PROFIT Margin (%) | 14.10 |
| Return On Networth / Equity (%) | 12.05 |
| Return On Networth /Employed (%) | 12.22 |
| Return On Assets (%) | 8.32 |
| Total Debt / Equity (X) | 0.40 |
| Asset Turnover Ratio (%) | 0.59 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 8,114.61 | 9,235.71 | 10,182.48 |
| Total Current Assets Annual | 14,912.54 | 16,443.75 | 9,703.75 |
| Non Current Assets Annual | 26,110.38 | 24,522.34 | 31,061.73 |
| Total Shareholders Funds Annual | 23,694.40 | 23,748.36 | 24,587.95 |
| Total Assets Annual | 41,064.79 | 40,987.49 | 40,765.48 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 8,114.61 |
| Total Current Assets Annual | 14,912.54 |
| Non Current Assets Annual | 26,110.38 |
| Total Shareholders Funds Annual | 23,694.40 |
| Total Assets Annual | 41,064.79 |
EPS (INR)
Expected
12.67
Reported
12.70
Surprise
0.24%
Jun 2024
EPS beaten by 0.24%
Mar 2024
EPS beaten by -0.17%
Dec 2023
EPS beaten by 0.36%
